AB 1864: Gene synthesis equipment manufacturers and providers.

This bill aims to regulate gene synthesis equipment and synthetic nucleic acids in California. To prevent the misuse of these technologies, manufacturers and providers must adhere to a framework for screening and safeguarding the benefits of gene synthesis while minimizing risk. The framework is based on federal law, regulations, or guidance documents that provide standards for the screening of synthetic nucleic acids. Manufacturers and providers must comply with the framework to avoid civil penalties, which do not exceed $1,000 per day. The state department of public health is authorized to adopt regulations that define the framework and may adopt different definitions of key terms. The department must submit a report to the legislature within one year of adopting new regulations. The bill's provisions are severable, allowing it to be implemented in parts if necessary.